Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, August 9, 2022
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
Tommie Reerink Maintained (ATRA) at Strong Sell with Decreased Target to $75 on, Aug 9th, 2022
Tommie Reerink of Goldman Sachs, Maintained "Atara Biotherapeutics, Inc." (ATRA) at Strong Sell with Decreased Target from $100 to $75 on, Aug 9th, 2022.
Tommie has made no other calls on ATRA in the last 4 months.
There are 5 other peers that have a rating on ATRA. Out of the 5 peers that are also analyzing ATRA, 2 agree with Tommie's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Anupam Rama of "JP Morgan" Downgraded from Buy to Hold and Held Target at $250 on, Wednesday, July 13th, 2022
- Benjamin Burnett of "Stifel" Downgraded from Strong Buy to Hold and Decreased Target to $125 on, Wednesday, July 13th, 2022
These are the ratings of the 3 analyists that currently disagree with Tommie
- Yigal Nochomovitz of "Citigroup" Downgraded from Hold to Strong Sell and Held Target at $75 on, Wednesday, July 20th, 2022
- Salveen Richter of "Goldman Sachs" Maintained at Strong Sell with Decreased Target to $100 on, Tuesday, May 24th, 2022
- Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $725 on, Monday, May 23rd, 2022
